NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 10:06AM ET
73.17
Dollar change
+0.12
Percentage change
0.16
%
IndexS&P 500 P/E22.75 EPS (ttm)3.22 Insider Own13.85% Shs Outstand122.24M Perf Week0.67%
Market Cap8.91B Forward P/E13.87 EPS next Y5.28 Insider Trans-0.06% Shs Float104.87M Perf Month4.54%
Enterprise Value13.41B PEG3.17 EPS next Q1.21 Inst Own97.85% Short Float7.63% Perf Quarter6.83%
Income407.00M P/S0.70 EPS this Y2.86% Inst Trans-17.85% Short Ratio5.08 Perf Half Y3.10%
Sales12.67B P/B2.70 EPS next Y8.23% ROA3.95% Short Interest8.01M Perf YTD5.74%
Book/sh27.08 P/C70.13 EPS next 5Y7.17% ROE11.78% 52W High82.49 -11.30% Perf Year14.17%
Cash/sh1.04 P/FCF16.19 EPS past 3/5Y-11.48% -2.15% ROIC7.35% 52W Low60.56 20.82% Perf 3Y-5.33%
Dividend Est.- EV/EBITDA12.53 Sales past 3/5Y0.73% 4.88% Gross Margin29.62% Volatility1.59% 2.13% Perf 5Y30.24%
Dividend TTM- EV/Sales1.06 EPS Y/Y TTM8.76% Oper. Margin6.10% ATR (14)1.46 Perf 10Y28.14%
Dividend Ex-Date- Quick Ratio0.75 Sales Y/Y TTM1.75% Profit Margin3.21% RSI (14)62.34 Recom2.47
Dividend Gr. 3/5Y- - Current Ratio1.38 EPS Q/Q22.96% SMA202.30% Beta0.87 Target Price76.15
Payout0.00% Debt/Eq0.97 Sales Q/Q-0.13% SMA504.78% Rel Volume0.32 Prev Close73.05
Employees25000 LT Debt/Eq0.67 EarningsMay 05 BMO SMA2002.39% Avg Volume1.58M Price73.17
IPONov 03, 1995 Option/ShortYes / Yes EPS/Sales Surpr.3.37% -1.83% Trades Volume69,176 Change0.16%
Date Action Analyst Rating Change Price Target Change
Feb-14-25Initiated Wells Fargo Equal Weight $80
Jan-06-25Upgrade BofA Securities Underperform → Buy $69 → $84
Dec-04-24Initiated Mizuho Neutral $75
Jul-22-24Upgrade Robert W. Baird Neutral → Outperform $81 → $92
Feb-26-24Initiated Leerink Partners Market Perform $78
Dec-12-23Upgrade JP Morgan Neutral → Overweight $71 → $82
Nov-10-23Upgrade Stifel Hold → Buy $70
Aug-08-22Upgrade UBS Sell → Neutral $80
Jul-21-22Downgrade Goldman Buy → Neutral $93 → $85
Jun-14-22Downgrade Robert W. Baird Outperform → Neutral $103 → $88
Jun-30-25 09:40AM
Jun-26-25 05:47PM
09:45AM
05:36AM
Jun-25-25 01:58PM
12:01AM Loading…
Jun-24-25 12:01AM
Jun-12-25 09:40AM
Jun-11-25 11:35PM
Jun-10-25 09:45AM
Jun-04-25 11:30AM
Jun-03-25 11:14AM
Jun-02-25 06:45PM
May-27-25 09:40AM
May-26-25 08:30AM
May-20-25 06:30AM
04:10PM Loading…
May-16-25 04:10PM
09:46AM
May-15-25 06:30AM
May-09-25 12:37AM
May-06-25 06:30AM
03:03AM
May-05-25 11:25PM
04:26PM
01:00PM
08:46AM
07:10AM
06:06AM
06:00AM
May-01-25 10:01AM
07:45AM
01:08PM Loading…
Apr-29-25 01:08PM
08:00AM
Apr-28-25 12:20PM
10:00AM
09:19AM
05:01AM
Apr-22-25 06:30AM
Apr-10-25 11:33AM
Apr-09-25 04:30PM
Apr-08-25 06:30AM
Apr-07-25 06:30AM
Mar-27-25 11:30AM
Mar-25-25 09:00AM
Mar-18-25 05:11AM
Mar-12-25 11:30AM
06:30AM
Mar-11-25 06:30AM
Mar-10-25 05:03AM
Mar-04-25 08:06AM
04:01AM
Mar-03-25 06:30AM
Feb-26-25 06:30AM
02:03AM
12:06AM
Feb-25-25 07:10AM
06:21AM
06:17AM
06:00AM
Feb-24-25 08:04AM
Feb-20-25 09:15AM
Feb-14-25 04:08AM
Feb-12-25 06:30AM
Feb-10-25 06:30AM
Feb-05-25 09:00AM
Jan-29-25 10:31AM
09:04AM
08:04AM
07:00AM
05:45AM
Jan-23-25 06:30AM
Jan-22-25 04:37PM
Jan-16-25 06:42AM
Jan-15-25 06:30AM
Jan-14-25 09:25AM
Jan-09-25 06:30AM
Jan-07-25 12:03PM
Dec-26-24 09:00PM
Dec-17-24 06:30AM
Dec-13-24 09:40AM
Dec-12-24 02:32PM
Dec-05-24 11:30AM
Nov-26-24 09:40AM
Nov-23-24 05:00AM
Nov-21-24 06:30AM
03:59AM
Nov-20-24 06:30AM
Nov-18-24 04:51PM
01:35PM
Nov-16-24 10:12AM
Nov-06-24 02:15AM
01:46AM
Nov-05-24 12:11PM
09:30AM
07:11AM
07:10AM
06:10AM
06:00AM
Oct-31-24 01:23PM
09:15AM
Oct-29-24 10:01AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LASKAWY PHILIP ADirectorMar 19 '25Sale71.042,604184,99924,805Mar 20 04:28 PM
Connett Bradford CCEO, NA Distribution GroupMar 19 '25Sale71.154,036287,16162,688Mar 20 04:19 PM
Connett Bradford COfficerMar 19 '25Proposed Sale71.154,036287,161Mar 19 04:46 PM
LASKAWY PHILIP ADirectorMar 19 '25Proposed Sale71.042,604184,999Mar 19 02:14 PM
KUEHN KURT PDirectorMar 05 '25Sale71.552,787199,39615,687Mar 06 04:31 PM
KUEHN KURT PDirectorMar 05 '25Proposed Sale71.552,787199,396Mar 05 04:45 PM
Ettinger Michael SEVP & Chief Operating OfficerNov 18 '24Sale75.0012,240918,00087,706Nov 20 04:15 PM
Ettinger Michael SOfficerNov 18 '24Proposed Sale75.0012,240918,000Nov 18 03:05 PM
McGlynn LoreleiSVP, Chief Human Res. OfficerSep 06 '24Sale69.3021,0351,457,72671,833Sep 09 05:19 PM
McGlynn LoreleiOfficerSep 06 '24Proposed Sale69.9321,0351,470,998Sep 06 11:38 AM
MLOTEK MARK EEVP, Chief Strategic OfficerAug 14 '24Sale69.123,000207,36087,851Aug 15 04:36 PM
MLOTEK MARK EOfficerAug 14 '24Proposed Sale69.123,000207,353Aug 14 12:27 PM